These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4053389)

  • 1. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylsuccinate and mesaconate in urine of patients treated with sodium benzoate.
    Maeda E; Matsuo M; Saiki K; Nakamura H; Matsuo T; Takemine H
    Acta Paediatr Jpn; 1989 Dec; 31(6):721-6. PubMed ID: 2533792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic conjugation of some carboxylic acids in the horse.
    Marsh MV; Caldwell J; Smith RL; Horner MW; Houghton E; Moss MS
    Xenobiotica; 1981 Oct; 11(10):655-63. PubMed ID: 7324500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
    Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
    Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperammonemia with sodium benzoate.
    Kodama H; Kamoshita S; Motokawa Y
    J Pediatr; 1983 Sep; 103(3):498. PubMed ID: 6886925
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective management of a child with neonatal citrullinemia.
    Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
    J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of sodium benzoate in newborn infants with hyperammonemia.
    Green TP; Marchessault RP; Freese DK
    J Pediatr; 1983 May; 102(5):785-90. PubMed ID: 6842341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.
    Batshaw ML; Brusilow SW
    J Pediatr; 1980 Dec; 97(6):893-900. PubMed ID: 7441417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On combination therapy with benzoate and piridoxilate.
    Cyr DM; Tremblay GC
    Am J Dis Child; 1989 Dec; 143(12):1392. PubMed ID: 2589268
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of the glycine cleavage system in hyperammonemia treated with benzoate.
    Kodama H; Fujiwara K; Motokawa Y; Tajiri H; Nose O; Kamoshita S
    Tohoku J Exp Med; 1983 Jul; 140(3):337-8. PubMed ID: 6623463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine gas chromatographic/mass spectrometric analysis of urinary organic acids. Results over a three-year period.
    Divry P; Vianey-Liaud C; Cotte J
    Biomed Environ Mass Spectrom; 1987 Nov; 14(11):663-8. PubMed ID: 2962675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of benzoic acid and hippuric acid in human plasma and urine by high-performance liquid chromatography.
    Kubota K; Horai Y; Kushida K; Ishizaki T
    J Chromatogr; 1988 Mar; 425(1):67-75. PubMed ID: 3360879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rationale for the use of sodium benzoate in clinical hepatology].
    Poo JL; Cervera E; de Hoyos A; Gil S; Cadena M; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():101-5. PubMed ID: 19256146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.